source
- Experts discuss emerging therapies shaping the future of relapsed and refractory multiple myelomaIn a recent opinion segment, Dr. Ajay Nooka and Dr. Noopur Raje explore how new treatments and ongoing trials are influencing the landscape for patients with relapsed and refractory multiple myelom…
- Experts discuss emerging MET-driven resistance data shaping second-line therapy for EGFR-mutated lung cancerIn a recent video segment, Dr. Jacob Sands sits down with Dr. Heather Wakelee to talk about the impact of new findings on MET-driven resistance in EGFR‑mutated non‑small cell lung cancer. The conv…